source
- FDA approves Orca Bio's T cell therapy Tregzi to lower transplant complications in blood cancer patientsThe U.S. Food and Drug Administration has granted approval to Orca Bio's T cell therapy aimed at improving outcomes for patients undergoing blood cancer transplants. The therapy, named Tregzi, is…
- BridgeBio secures $1 billion in equity financing ahead of three upcoming drug launchesBridgeBio Pharma announced it has raised about $1 billion through a preferred equity transaction. The new capital will strengthen its balance sheet as the company prepares three potential drug lau…